What is intensity-modulated radiotherapy?
Intensity-modulated radiotherapy (IMRT) is an advanced form of external beam radiotherapy that shapes the radiation dose very closely to the tumour. It does this by varying, or “modulating”, the strength of the radiation across each beam, so that the tumour receives a high dose while nearby healthy organs receive much less.
In older forms of radiotherapy, each beam delivered roughly the same dose across its whole width. This made it difficult to treat tumours that wrap around sensitive structures such as the spinal cord, salivary glands, bowel or bladder. With IMRT, the beam is broken up into many tiny sections called beamlets, each with its own strength. When many beams from different angles are combined, the high-dose area can be curved to fit an irregular tumour shape.
IMRT is now the standard technique for many cancers, including head and neck cancer, prostate cancer, cervical cancer and anal cancer. It is delivered by a machine called a linear accelerator, in daily treatments over several weeks. A rotating version, called volumetric modulated arc therapy (VMAT), delivers IMRT while the machine moves around the body, which makes each treatment faster.
A brief history
Until the 1990s, radiotherapy was mostly planned using two-dimensional X-ray images, and beams were shaped using metal blocks. Three-dimensional planning based on CT scans followed. In the 1990s, computer-controlled metal leaves inside the treatment machine, called multileaf collimators, and powerful planning software made it possible to vary the intensity of each beam. IMRT entered routine use around 2000, and VMAT became widespread from the late 2000s.
1. Key facts at a glance
| Feature | Details |
|---|---|
| Type of treatment | External beam radiotherapy |
| Main uses | Head and neck, prostate, cervical, anal, brain and some breast cancers |
| How it is given | Linear accelerator; you lie still while the machine delivers the beams |
| Session length | Usually 10-20 minutes, with only a few minutes of beam time |
| Course length | Often 4-7 weeks of weekday treatments; shorter for some cancers |
| Can be combined with | Chemotherapy, surgery and hormone therapy |
| Main side effects | Depend on the area treated: skin redness, tiredness, sore mouth, bowel or bladder irritation |
2. How it works
Radiation and cancer cells
Radiation damages the DNA inside cells. Cancer cells are generally less able to repair this damage than healthy cells, so they are more likely to die. Splitting the treatment into many small daily doses, called fractions, gives healthy tissues time to recover between sessions.
How IMRT shapes the dose
| Feature | How it helps |
|---|---|
| Multileaf collimator | Dozens of thin metal leaves move during treatment to shape each beam |
| Inverse planning | The team sets dose targets and limits; the computer works out the beam pattern |
| Many beam angles or arcs | Spread the dose so that healthy tissue receives less |
| Steep dose fall-off | The dose drops sharply at the edge of the target |
Image guidance
Because IMRT is so precise, small shifts in position matter. Most centres use image-guided radiotherapy (IGRT), taking X-rays or a quick CT scan on the treatment couch before each session to check that everything lines up.
Comparison with other radiotherapy techniques
| Technique | Main difference from IMRT |
|---|---|
| 3D conformal radiotherapy | Beams are shaped to the tumour outline but have a uniform strength |
| Stereotactic radiotherapy | Very high doses in a few sessions to small targets |
| Proton beam therapy | Uses protons, which stop at a set depth |
| Brachytherapy | Radiation is delivered from sealed sources put within or beside the tumour |
3. Who it is for
Conditions treated
| Condition | Role of IMRT |
|---|---|
| Nasopharyngeal carcinoma | Standard technique, often with chemotherapy |
| HPV-related oropharyngeal squamous cell carcinoma | Standard, sparing the salivary glands and swallowing muscles |
| Laryngeal squamous cell carcinoma | Commonly used, sometimes with chemotherapy |
| Prostate adenocarcinoma | Standard external beam technique, sparing the rectum and bladder |
| Cervical cancer | With chemotherapy, followed by brachytherapy |
| Anal squamous cell carcinoma | With chemotherapy, reducing skin and bowel side effects |
| Glioblastoma | Often used to spare nearby brain structures |
| Invasive ductal carcinoma | Used for some breast treatments to make the dose more even |
When IMRT is particularly helpful
| Situation | Reason |
|---|---|
| Tumour wraps around a sensitive organ | The dose can bend around it |
| Several areas need different doses | A single plan can treat them at the same time |
| Previous radiotherapy nearby | Helps keep doses to healthy tissue within safe limits |
| Irregularly shaped targets | The dose can be sculpted to fit |
4. Before treatment
| Step | Why it is done |
|---|---|
| Consultation | Discusses benefits, side effects and alternatives |
| Planning CT scan | Done in the treatment position |
| Immobilisation | A mask for head and neck treatment, or supports for the body |
| Small tattoos or marks | Help line you up each day |
| MRI or PET fusion | Helps the team outline the target accurately |
| Dental check | Before head and neck treatment |
| Bladder and bowel instructions | For pelvic treatment, to keep organs in a consistent position |
The planning process
After the planning scan, the doctor outlines the tumour and the areas at risk, and the planning team outlines nearby healthy organs. Physicists and dosimetrists then create the plan using specialised software. Every IMRT plan is checked before treatment begins, often by measuring the dose on a test device. This process usually takes one to three weeks.
Head and neck masks
For treatment of the head and neck, a mesh mask is moulded to your face and shoulders. It holds you still during each session. Many people find the mask strange at first, but staff can help, and it becomes easier with time.
5. What to expect: step by step
| Step | What happens |
|---|---|
| 1. Arrival | Check in and change if needed |
| 2. Positioning | Radiographers line you up using the marks or mask |
| 3. Imaging | X-rays or a CT scan check your position |
| 4. Treatment | The machine moves around you; you hear buzzing but feel nothing |
| 5. Finish | You can usually go home straight away |
| 6. Weekly review | A doctor, nurse or radiographer checks side effects |
During the course
Treatment is usually given once a day on weekdays. You can usually drive and carry on many normal activities, although tiredness tends to build up. You are not radioactive and can be with family, including children and pregnant women.
6. Side effects and risks
Side effects depend on which part of the body is treated.
| Area treated | Common short-term side effects | Possible long-term effects |
|---|---|---|
| Head and neck | Sore mouth and throat, dry mouth, taste changes, skin redness | Dry mouth, swallowing difficulty, dental problems |
| Prostate | Needing to pass urine more often, bowel irritation | Bowel or bladder changes, erection problems |
| Cervix or anus | Diarrhoea, bladder irritation, skin soreness | Bowel changes, vaginal narrowing, early menopause |
| Brain | Tiredness, hair loss in the treated area | Memory and thinking changes in some people |
| Breast | Skin redness and peeling | Breast firmness or shape change |
Dry mouth
The salivary glands are very sensitive to radiation. Sparing them is one of the main reasons IMRT is used in head and neck cancer. In the PARSPORT trial, 38% of people treated with parotid-sparing IMRT had at least moderate dry mouth after 12 months, compared with 74% of those treated with conventional radiotherapy (Nutting et al., 2011).
Tiredness
Tiredness is frequent and may linger for several weeks once the course is over. In PARSPORT, short-term fatigue was more common with IMRT, possibly because a wider area of tissue receives a low dose (Nutting et al., 2011).
Skin reactions
IMRT can make the dose more even across the skin. In a Canadian breast trial, peeling, weeping skin (moist desquamation) affected 31% of women treated with breast IMRT compared with 48% with a standard technique (Pignol et al., 2008).
Eating well during head and neck treatment
A sore mouth and throat can make eating difficult in the later weeks of head and neck radiotherapy. A dietitian will usually see you before and during treatment. Soft, moist foods, high-energy drinks and regular painkillers taken before meals can help. Some people need a feeding tube for a while to keep their weight up, and this is a normal part of care rather than a sign that treatment is failing.
Looking after your pelvis during treatment
For prostate, cervical and anal treatment, you may be asked to have a comfortably full bladder and an empty bowel before each session, so that these organs sit in the same place every day. Following these instructions closely helps protect the bladder and bowel.
7. Results and outlook
| Study | Main finding |
|---|---|
| PARSPORT trial, head and neck cancer, 94 patients | Parotid-sparing IMRT roughly halved the rate of significant dry mouth at 12 months, and the difference was still present at 24 months (Nutting et al., 2011) |
| Nasopharyngeal carcinoma trial, 616 patients | Five-year overall survival was 79.6% with IMRT versus 67.1% with two-dimensional radiotherapy, with fewer side effects (Peng et al., 2012) |
| Canadian breast IMRT trial, 331 women analysed | Breast IMRT reduced moist skin peeling during and after radiotherapy (Pignol et al., 2008) |
What the results mean
IMRT does not make radiation more powerful against cancer. Its main benefit is precision, which allows a higher or more even dose to the tumour while protecting healthy tissues. This usually means fewer long-term side effects and, in some cancers such as nasopharyngeal carcinoma, better cancer control.
8. Recovery and aftercare
| Tip | Why |
|---|---|
| Moisturise skin as advised | Reduces soreness |
| Wear loose, soft clothing | Protects the treated skin |
| Keep up fluids and nutrition | Particularly for head and neck or pelvic treatment |
| Follow mouth care instructions | Reduces infection and soreness |
| Rest but stay gently active | Helps with fatigue |
| Report severe pain, bleeding or inability to eat | Support or treatment changes may be needed |
After the course
Side effects often peak in the last week of treatment or the first week or two after it, and then gradually settle over several weeks. A follow-up appointment is usually arranged a few weeks after treatment ends, with scans at a later point to check the response.
Long-term care
Some late effects can appear months or years later. Long-term follow-up allows these to be found and treated. For head and neck patients, regular dental checks and swallowing exercises are important.
9. Alternatives
| Alternative | When it is considered |
|---|---|
| Proton beam therapy | Selected tumours near critical structures, especially in children |
| Stereotactic body radiotherapy (SBRT) | Small tumours treated in a few high-dose sessions |
| Stereotactic radiosurgery | Small brain tumours or metastases |
| Brachytherapy | Prostate, cervical and some other cancers |
| Palliative radiotherapy | Shorter, simpler courses to relieve symptoms |
| Surgery | Many cancers can be treated with surgery instead of, or as well as, radiotherapy |
10. Frequently asked questions
| Question | Answer |
|---|---|
| Does IMRT hurt? | No, you feel nothing during treatment |
| Will I be radioactive? | No, external radiotherapy does not make you radioactive |
| Why does planning take so long? | Each IMRT plan is individually designed and checked |
| Is IMRT the same as VMAT? | VMAT is a type of IMRT delivered while the machine rotates |
| Can I work during treatment? | Many people do, though tiredness builds up |
| Will I lose my hair? | Only in the area being treated |
| Can I have IMRT again later? | Sometimes, depending on the doses already given to nearby organs |
| Is IMRT available everywhere? | It is now standard in most radiotherapy centres |
| What if I miss a session? | It is usually added on at the end; tell the team |
11. Questions to ask your care team
- Why is IMRT recommended for me?
- How many sessions will I need?
- Which healthy organs are near the treatment area?
- What side effects should I expect, and when?
- Will I have chemotherapy at the same time?
- What long-term effects should I watch for?
Resources
- Nutting, C.M. et al. (2011) ‘Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial’, The Lancet Oncology, 12(2), pp. 127-136.
- Peng, G. et al. (2012) ‘A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma’, Radiotherapy and Oncology, 104(3), pp. 286-293.
- Pignol, J.P. et al. (2008) ‘A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis’, Journal of Clinical Oncology, 26(13), pp. 2085-2092.
- National Cancer Institute (2026) External Beam Radiation Therapy for Cancer. Available at: https://www.cancer.gov/about-cancer/treatment/types/radiation-therapy/external-beam (Accessed: October 2026).
- National Cancer Institute (2026) Nasopharyngeal Carcinoma Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/head-and-neck/hp/adult/nasopharyngeal-treatment-pdq (Accessed: October 2026).
Prepared by the editorial team, October 2026.